Amendments to proposals by the DNA Shareholders' Nomination Committee to the company's Annual General Meeting 2018

DNA PLC STOCK EXCHANGE RELEASE 15 MARCH 2018, 10:30 am (EET)

The proposals for decisions by the Shareholders' Nomination Committee of DNA Plc were announced on 18 January 2018 and the notice of the General Meeting on 2 February 2018. DNA's Annual General Meeting will be held on 22 March 2018 at 1 pm.

The DNA Shareholders' Nomination Committee has decided to amend its proposals for the decisions on the number of Members of the Board of Directors (item 11 of the notice of the General Meeting) and the composition of the Board of Director (item 12 of the notice of the General Meeting) following the notice of the General Meeting as follows:

According to the notice of the General Meeting, the proposed Board of Directors consists of seven Members.

The Shareholders' Nomination Committee has decided to amend its proposal to six Members of the Board of Directors.

According to the notice of the General Meeting, the proposed Members of the Board of Directors are Pertti Korhonen, Heikki Mäkijärvi, Anu Nissinen, Tero Ojanperä, Jukka Ottela, Margus Schults and Kirsi Sormunen.

The Shareholders' Nomination Committee has decided to amend its proposal and proposes the re-election of current Members of the Board of Directors Pertti Korhonen, Anu Nissinen, Tero Ojanperä, Jukka Ottela, Margus Schults and Kirsi Sormunen.

In deviation of the original proposal, Heikki Mäkijärvi has announced his unavailability to continue in his position due to a new professional commitment which might cause a conflict of interest with DNA. 

The Nomination Committee also proposes that Pertti Korhonen continue as the Chairman of the Board of Directors.

Background information on the nominees is available online at the address: https://corporate.dna.fi/dna-in-brief#hallitus

Regarding the remuneration of the Board of Directors, the Nomination Committee proposes no amendments to the notice of the General Meeting.

Shareholders' Nomination Committee

The Nomination Committee consists of three members appointed by the shareholders. The members of the Nomination Committee are Tommi Aurejärvi (Chairman, appointed by Finda Telecoms Oy), Seppo Vikström (appointed by PHP Holding Oy) and Esko Torsti (appointed by Ilmarinen Mutual Pension Insurance Company). In addition, the Chairman of DNA's Board of Directors participates in committee work in an expert capacity.

The three shareholders entered in the company's shareholders' register maintained by Euroclear Finland Ltd, whose portion of the votes produced by all the shares in the company according to the shareholders' register are the greatest on 1 September, shall have the right to appoint members representing shareholders.

Further information:
Tommi Aurejärvi, Chairman of the Shareholders' Nomination Committee, tel. +358 (0)50 1973
DNA Corporate Communications, tel. +358 (0)44 044 8000, [email protected]
www.dna.fi/agm

DNA Plc is a Finnish telecommunications group providing high-quality voice, data and TV services for communication, entertainment and working. DNA is Finland's largest cable operator and the leading pay TV provider in both cable and terrestrial networks. For DNA, the key area for growth in corporate business is the new way of working, independent of time and place, facilitated by smart terminal devices, diverse communications services and rapid connections. In 2017, DNA recorded net sales of EUR 886 million and an operating profit of EUR 124 million. DNA has more than 3.9 million subscriptions in its fixed and mobile communications networks. The Group also includes DNA Store, Finland's largest retail chain selling mobile phones. DNA shares are listed on Nasdaq Helsinki Ltd. For more information, visit www.dna.fi or follow us on Twitter @DNA_fi and Facebook.